May 30, 2025
June 9, 2025
This week’s newsletter included:
- Rep. Blake Moore Holds Tariff Roundtable
- Rep. Blake Moore Urges Caution on Possible Section 232 Pharma Tariffs
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- UofU Startup, Eyescreen, Receives Funding to Improve Drug Development for Vision Loss
- Halia Therapeutics CEO Dr. David Bearss Delivered Keynote Address at Med Investment Forum 2025 in Abu Dhabi
- The Healthcare Technology Report: The Top 25 Healthcare AI Executives of 2025
- Utah Business Announces 30 Women to Watch 2025
- Considerations for Life Sciences Employers When Planning RIFs
- Seek Labs’ President, Keith Marmer, Transitions to Board of Directors
- First Successful Allogeneic Stem Cell Transplant Using Deceased Donor in Blood Cancer Clinical Trial
- Teva Reaffirms “Pivot to Growth” Strategy Progress
- Myriad Genetics Highlights New Research Advancements, Oncology Innovations at 2025 ASCO Annual Meeting
- Don’t Miss BioUtah’s Exclusive Biosphere Magazine Promotional Opportunity
- Nominations Now Open: 2025 Innovations in Regulatory Science & Policy Awards
- Utah Business: Nominations for Most Influential Women Open
- Utah Business: Nominations for Innovation Awards Open
Featured New BioUtah Elite Bronze Member: Scientia
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize